Search

Author/Creator Peters, Godefridus

3. Cytidine deaminase enzymatic activity is a prognostic biomarker in gemcitabine/platinum-treated advanced non-small-cell lung cancer: a prospective validation study. Issue 11 (27th November 2018)

Authors:
Tibaldi, Carmelo; Camerini, Andrea; Tiseo, Marcello; Mazzoni, Francesca; Barbieri, Fausto; Vittimberga, Isabella; Brighenti, Matteo; Boni, Luca; Baldini, Editta; Gilli, Annalisa; Honeywell, Richard; Chartoire, Myriam; Peters, Godefridus; Giovannetti, Elisa
Journal:
British journal of cancer
Issue:
Volume 119:Issue 11(2018)
Page Start:
1326
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Phospho-Akt overexpression is prognostic and can be used to tailor the synergistic interaction of Akt inhibitors with gemcitabine in pancreatic cancer. Issue 1 (December 2017)

Authors:
Massihnia, Daniela; Avan, Amir; Funel, Niccola; Maftouh, Mina; van Krieken, Anne; Granchi, Carlotta; Raktoe, Rajiv; Boggi, Ugo; Aicher, Babette; Minutolo, Filippo; Russo, Antonio; Leon, Leticia; Peters, Godefridus; Giovannetti, Elisa
Journal:
Journal of hematology & oncology
Issue:
Volume 10:Issue 1(2017)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗